Tag: Drug development challenges

news-01122024-004155

Biotech Update: Roche’s TIGIT Struggles and Missed Alzheimer’s Target

Happy Tuesday! I'm Adam Feuerstein, and I'm here to bring you the latest updates in the world of biotech. It seems like all the...
news-20102024-151040

Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets

Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in...

BREAKING NEWS

Top News